Related Experiment Video

Updated: May 18, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Biomarkers of platelet activation in acute coronary syndromes

Patrizia Ferroni1, Silvia Riondino, Natale Vazzana

  • 1Department of Advanced Biotechnologies and Bioimaging, IRCCS San Raffaele Pisana, Rome, Italy.

Thrombosis and Haemostasis
|September 28, 2012
PubMed

Insights

Platelet activation in acute coronary syndromes (ACS) is linked to adverse events. Monitoring in vivo platelet activation offers potential clinical benefits for ACS patients.

Area of Science:

  • Cardiology
  • Hematology
  • Thrombosis Research

Background:

  • Platelets play a key role in arterial thrombosis, particularly in acute coronary syndromes (ACS).
  • Evidence links repeated platelet activation on vulnerable plaques to fatal coronary events.
  • The correlation between in vivo platelet activation, clinical outcomes, and platelet function tests is not well understood.

Purpose of the Study:

  • To review current biomarkers for in vivo platelet activation in ACS.
  • To discuss the advantages, disadvantages, and potential pitfalls of these biomarkers.
  • To present emerging data on the clinical utility of monitoring in vivo platelet activation in ACS.

Main Methods:

  • Review of existing literature on platelet activation biomarkers in ACS.
  • Analysis of advantages, disadvantages, and pre-analytical considerations for biomarkers.
  • Evaluation of emerging clinical data regarding monitoring in vivo platelet activation.

Main Results:

  • Current biomarkers for in vivo platelet activation in ACS have varying utility.
  • Pre-analytical factors can significantly impact biomarker reliability.
  • Emerging data suggest clinical value in monitoring platelet activation in ACS.

Conclusions:

  • Understanding and monitoring in vivo platelet activation is crucial in managing ACS.
  • Development of specific, reliable, and easily measurable biomarkers is needed.
  • Monitoring platelet activation may improve clinical decision-making and patient outcomes in ACS.

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...